Literature DB >> 25495196

Lower extremity kinematics of athletics curve sprinting.

Tobias Alt1, Kai Heinrich, Johannes Funken, Wolfgang Potthast.   

Abstract

Curve running requires the generation of centripetal force altering the movement pattern in comparison to the straight path run. The question arises which kinematic modulations emerge while bend sprinting at high velocities. It has been suggested that during curve sprints the legs fulfil different functions. A three-dimensional motion analysis (16 high-speed cameras) was conducted to compare the segmental kinematics of the lower extremity during the stance phases of linear and curve sprints (radius: 36.5 m) of six sprinters of national competitive level. Peak joint angles substantially differed in the frontal and transversal plane whereas sagittal plane kinematics remained unchanged. During the prolonged left stance phase (left: 107.5 ms, right: 95.7 ms, straight: 104.4 ms) the maximum values of ankle eversion (left: 12.7°, right: 2.6°, straight: 6.6°), hip adduction (left: 13.8°, right: 5.5°, straight: 8.8°) and hip external rotation (left: 21.6°, right: 12.9°, straight: 16.7°) were significantly higher. The inside leg seemed to stabilise the movement in the frontal plane (eversion-adduction strategy) whereas the outside leg provided and controlled the motion in the horizontal plane (rotation strategy). These results extend the principal understanding of the effects of curve sprinting on lower extremity kinematics. This helps to increase the understanding of nonlinear human bipedal locomotion, which in turn might lead to improvements in athletic performance and injury prevention.

Entities:  

Keywords:  adduction; eversion; external rotation; joint angles; sprint kinematics

Mesh:

Year:  2014        PMID: 25495196     DOI: 10.1080/02640414.2014.960881

Source DB:  PubMed          Journal:  J Sports Sci        ISSN: 0264-0414            Impact factor:   3.337


  7 in total

1.  A Multifactorial Approach to Overuse Running Injuries: A 1-Year Prospective Study.

Authors:  Sara C Winter; Susan Gordon; Sara M Brice; Daniel Lindsay; Sue Barrs
Journal:  Sports Health       Date:  2020-01-29       Impact factor: 3.843

2.  How to Maintain Maximal Straight Path Running Speed on a Curved Path in Sprint Events.

Authors:  Hayato Ohnuma; Masanobu Tachi; Akihito Kumano; Yuichi Hirano
Journal:  J Hum Kinet       Date:  2018-06-13       Impact factor: 2.193

3.  Long jumpers with and without a transtibial amputation have different three-dimensional centre of mass and joint take-off step kinematics.

Authors:  Johannes Funken; Steffen Willwacher; Kai Heinrich; Ralf Müller; Hiroaki Hobara; Alena M Grabowski; Wolfgang Potthast
Journal:  R Soc Open Sci       Date:  2019-04-17       Impact factor: 2.963

4.  Influence of playing position and laterality in centripetal force and changes of direction in elite soccer players.

Authors:  Paulino Granero-Gil; Carlos D Gómez-Carmona; Alejandro Bastida-Castillo; Daniel Rojas-Valverde; Ernesto de la Cruz; José Pino-Ortega
Journal:  PLoS One       Date:  2020-04-23       Impact factor: 3.240

5.  Influence of Contextual Variables in the Changes of Direction and Centripetal Force Generated during an Elite-Level Soccer Team Season.

Authors:  Paulino Granero-Gil; Alejandro Bastida-Castillo; Daniel Rojas-Valverde; Carlos D Gómez-Carmona; Ernesto de la Cruz Sánchez; José Pino-Ortega
Journal:  Int J Environ Res Public Health       Date:  2020-02-04       Impact factor: 3.390

6.  Relationship between lateral differences in the cross-sectional area of the psoas muscle and curve running time.

Authors:  Nobuaki Tottori; Toshiyuki Kurihara; Mitsuo Otsuka; Tadao Isaka
Journal:  J Physiol Anthropol       Date:  2016-01-26       Impact factor: 2.867

7.  Evaluation of Lower Limb Muscle Electromyographic Activity during 400 m Indoor Sprinting among Elite Female Athletes: A Cross-Sectional Study.

Authors:  Przemysław Pietraszewski; Artur Gołaś; Michał Krzysztofik; Marta Śrutwa; Adam Zając
Journal:  Int J Environ Res Public Health       Date:  2021-12-14       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.